Skip to content

Price / sales at other companies

Intel logo
IntelINTC
4.1×+2.3×
Johnson & Johnson logo
Johnson & JohnsonJNJ
6.1×+1.6×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
4.5×-5.5×
Mobileye Global Inc. logo
Mobileye Global Inc.MBLY
2.9×-3.4×
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
8.8×-6.6×
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
0.6×-0.2×

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Calculated from Rafael Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s price / sales?
Rafael Holdings, Inc. (RFL) reported price / sales of 67.4× in Q1 2026.
How has Rafael Holdings, Inc.'s price / sales changed year-over-year?
Rafael Holdings, Inc.'s price / sales decreased by 21.4% year-over-year, from 85.8× to 67.4×.
What is the long-term trend for Rafael Holdings, Inc.'s price / sales?
Over 3 years (2022 to 2025), Rafael Holdings, Inc.'s price / sales has grown at a -12.7% compound annual growth rate (CAGR), from 97.4× to 64.7×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.